Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Shares Outstanding (2022 - 2025)

Prokidney (PROK) has disclosed Shares Outstanding for 4 consecutive years, with $141.8 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding fell 13.37% to $141.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $141.8 million through Dec 2025, down 13.37% year-over-year, with the annual reading at $141.8 million for FY2025, 13.37% down from the prior year.
  • Shares Outstanding for Q4 2025 was $159.3 million at Prokidney, up from $136.0 million in the prior quarter.
  • The five-year high for Shares Outstanding was $186.5 million in Q1 2022, with the low at $61.5 million in Q4 2022.
  • Average Shares Outstanding over 4 years is $139.6 million, with a median of $159.3 million recorded in 2025.
  • The sharpest move saw Shares Outstanding skyrocketed 182.48% in 2023, then fell 13.37% in 2025.
  • Over 4 years, Shares Outstanding stood at $61.5 million in 2022, then skyrocketed by 173.48% to $168.3 million in 2023, then decreased by 2.74% to $163.7 million in 2024, then dropped by 13.37% to $141.8 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $141.8 million, $159.3 million, and $159.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.